Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOrelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study.AuthorsDeng, Lijuan; Li, Zhiming; Zhang, Huilai; Huang, Haiwen; Hu, Jianda; Liu, Lihong; Liu, Ting; Jin, Jie; Zhu, Zunmin; Li, Wenyu; Huang, Zhenqian; Huang, Wenrong; Zhou, Keshu; Yang, Haiyan; Zhang, Mingzhi; Ding, Kaiyang; Zhou, Hui; Hu, Yu; Shuang, Yuerong; Cao, JunningPublicationAmerican Journal of Hematology, 2023, Vol 98, Issue 11, p1742ISSN0361-8609Publication typeArticleDOI10.1002/ajh.27064